EW - Edwards Lifesciences Q1 2024 Earnings Preview
2024-04-24 17:20:27 ET
More on Edwards Lifesciences
- Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained)
- Edwards Lifesciences Corporation (EW) Q4 2023 Earnings Call Transcript
- BofA upgrades Edwards to buy, says double-digit growth is back
- Edwards Lifesciences Non-GAAP EPS of $0.64 in-line, revenue of $1.53B beats by $30M
- Seeking Alpha’s Quant Rating on Edwards Lifesciences